Literature DB >> 18998599

Keeping the noise down: common random numbers for disease simulation modeling.

Natasha K Stout1, Sue J Goldie.   

Abstract

Disease simulation models are used to conduct decision analyses of the comparative benefits and risks associated with preventive and treatment strategies. To address increasing model complexity and computational intensity, modelers use variance reduction techniques to reduce stochastic noise and improve computational efficiency. One technique, common random numbers, further allows modelers to conduct counterfactual-like analyses with direct computation of statistics at the individual level. This technique uses synchronized random numbers across model runs to induce correlation in model output thereby making differences easier to distinguish as well as simulating identical individuals across model runs. We provide a tutorial introduction and demonstrate the application of common random numbers in an individual-level simulation model of the epidemiology of breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18998599      PMCID: PMC2761656          DOI: 10.1007/s10729-008-9067-6

Source DB:  PubMed          Journal:  Health Care Manag Sci        ISSN: 1386-9620


  8 in total

1.  Incorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease.

Authors:  Oguzhan Alagoz; Cindy L Bryce; Steven Shechter; Andrew Schaefer; Chung-Chou H Chang; Derek C Angus; Mark S Roberts
Journal:  Med Decis Making       Date:  2005 Nov-Dec       Impact factor: 2.583

2.  Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.

Authors:  Steven M Shechter; Andrew J Schaefer; R Scott Braithwaite; Mark S Roberts
Journal:  Med Decis Making       Date:  2006 Sep-Oct       Impact factor: 2.583

3.  The cost effectiveness of combination antiretroviral therapy for HIV disease.

Authors:  K A Freedberg; E Losina; M C Weinstein; A D Paltiel; C J Cohen; G R Seage; D E Craven; H Zhang; A D Kimmel; S J Goldie
Journal:  N Engl J Med       Date:  2001-03-15       Impact factor: 91.245

Review 4.  Recent developments in decision-analytic modelling for economic evaluation.

Authors:  Milton C Weinstein
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  The MISCAN simulation program for the evaluation of screening for disease.

Authors:  J D Habbema; G J van Oortmarssen; J T Lubbe; P J van der Maas
Journal:  Comput Methods Programs Biomed       Date:  1985-05       Impact factor: 5.428

6.  A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.

Authors:  Ruth Davies; David Crabbe; Paul Roderick; Jonathan R Goddard; James Raftery; Praful Patel
Journal:  Health Care Manag Sci       Date:  2002-11

7.  The Wisconsin Breast Cancer Epidemiology Simulation Model.

Authors:  Dennis G Fryback; Natasha K Stout; Marjorie A Rosenberg; Amy Trentham-Dietz; Vipat Kuruchittham; Patrick L Remington
Journal:  J Natl Cancer Inst Monogr       Date:  2006

8.  A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.

Authors:  Sue J Goldie; Daniel Grima; Michele Kohli; Thomas C Wright; Milton Weinstein; Eduardo Franco
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

  8 in total
  14 in total

1.  Economic evaluations with agent-based modelling: an introduction.

Authors:  Jagpreet Chhatwal; Tianhua He
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  Validation of a Cardiovascular Disease Policy Microsimulation Model Using Both Survival and Receiver Operating Characteristic Curves.

Authors:  Ankur Pandya; Stephen Sy; Sylvia Cho; Sartaj Alam; Milton C Weinstein; Thomas A Gaziano
Journal:  Med Decis Making       Date:  2017-05-10       Impact factor: 2.583

3.  Using common random numbers in health care cost-effectiveness simulation modeling.

Authors:  Daniel R Murphy; Robert W Klein; Lee J Smolen; Timothy M Klein; Stephen D Roberts
Journal:  Health Serv Res       Date:  2013-02-13       Impact factor: 3.402

4.  Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

Authors:  Jesse D Ortendahl; Allison L Diamant; Peter P Toth; Dasha Cherepanov; Amanda L Harmon; Michael S Broder
Journal:  Clin Cardiol       Date:  2018-11-28       Impact factor: 2.882

5.  Reducing C. difficile in children: An agent-based modeling approach to evaluate intervention effectiveness.

Authors:  Anna K Barker; Elizabeth Scaria; Oguzhan Alagoz; Ajay K Sethi; Nasia Safdar
Journal:  Infect Control Hosp Epidemiol       Date:  2020-02-13       Impact factor: 3.254

6.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

7.  Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation.

Authors:  John Graves; Shawn Garbett; Zilu Zhou; Jonathan S Schildcrout; Josh Peterson
Journal:  Med Decis Making       Date:  2021-03-18       Impact factor: 2.749

8.  Expected lifetime numbers and costs of fractures in postmenopausal women with and without osteoporosis in Germany: a discrete event simulation model.

Authors:  Florian Bleibler; Kilian Rapp; Andrea Jaensch; Clemens Becker; Hans-Helmut König
Journal:  BMC Health Serv Res       Date:  2014-06-30       Impact factor: 2.655

9.  Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.

Authors:  Rick A Vreman; Alex J Goodell; Luis A Rodriguez; Travis C Porco; Robert H Lustig; James G Kahn
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

10.  Cost-Effectiveness Analysis of Four Simulated Colorectal Cancer Screening Interventions, North Carolina.

Authors:  Kristen Hassmiller Lich; David A Cornejo; Maria E Mayorga; Michael Pignone; Florence K L Tangka; Lisa C Richardson; Tzy-Mey Kuo; Anne-Marie Meyer; Ingrid J Hall; Judith Lee Smith; Todd A Durham; Steven A Chall; Trisha M Crutchfield; Stephanie B Wheeler
Journal:  Prev Chronic Dis       Date:  2017-02-23       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.